Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant RecipientsJames Neuberger, Teun van Gelder, Patrizia Burra et al.|Transplantation|2017Cited by 309
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical TrialRobin K. Avery, Sophie Alain, Barbara D. Alexander et al.|Clinical Infectious Diseases|2021Cited by 299